Gain FREE ACCESS 

 

Reserve your seat!

Terms and Conditions  |  Privacy Policy

† You may still receive emails from us regarding any current registrations or orders.

All Rights Reserved. Forward ® 2017

EBD Group Inc., 3150 Pio Pico Drive, Suite 201, Carlsbad, CA, 92008



Tuesday, January 9, 4:30-5:30 pm
Hilton San Francisco Union Square

The growing pressure on drug companies to bring new rare disease therapies quickly and cost-effectively is giving rise to a variety of emerging business models. While there are several fully-integrated pharmaceutical companies in the space, others focus on licensing a platform technology, behaving more like an incubator, or driving an array of projects through a collaboration model.

  • What do companies gain or lose with such strategies?
  • How do they accelerate the development of new therapies?
  • How do investors view these models?

This compelling program will explore these and other impacts of the evolving business models.

Featured Speakers:

Sarah Boyce
Senior VP and Chief Business Officer
Ionis Pharmaceuticals, Inc

Neil Kumar 
CEO
BridgeBio

UPGRADE TO A FULL REGISTRATION:

  • Biotech Showcase™ 
  • One-to-one meetings in partneringONE®
  • Two and a half days of digital medicine and medtech programming
  • 70 curated digital medicine and medtech company presentations
  • Specialized sessions
  • Networking opportunities
Find out more!
Drivers of innovation: 
Evolving models in rare disease drug development

January 8–10, 2018
HILTON SAN FRANCISCO UNION SQUARE,
San Francisco, CA 94102 USA

Danny Levine 
Editor, RARE Daily; 
Host, RARECast; Principal, Levine Media Group

Presented by:

Brinda Balakrishnan
Group VP, Corporate and Business Development
BioMarin

Presented by:

Robert Pacifici
CSO
CHDI

Fix the following errors:
Hide